Determining the appropriate drug dosage is critically important for achieving best benefits. Initially, patients typically begin with a low quantity of roughly 2.4 Retatrutide dosing schedule mg, given each week via subcutaneous . This initial amount is then progressively increased every four periods, until a peak quantity of 10.8 mg, according to